Search results

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

A review of the risks of major congenital malformations and of adverse neurodevelopmental outcomes for antiepileptic drugs by the Commission on Human Medicines has confirmed that lamotrigine...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 07 January 2021

Evidence suggests an increased risk of aminoglycoside-associated ototoxicity in patients with mitochondrial mutations, including cases in which the patient’s aminoglycoside serum levels were within...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 24 May 2017

You can use our free e-learning modules to find out more about how and when to report suspected adverse drug reactions and earn CPD credits at the same time.

Read Summary

Type:

Safety Alerts (Add filter)

Type:

Implementation Support (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 17 July 2018

Following receipt of a third case of fatal medication error caused by the administration of Fungizone (a non-lipid-based formulation of amphotericin B) instead of a lipid-based formulation (AmBisome, ...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 08 March 2018

Pharmacists should tell people about the risk of fire when they discuss head lice eradication options.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 08 March 2018

The European Medicines Agency (EMA) has recommended the immediate suspension of the marketing authorisation and recall of daclizumab (Zinbryta) in the EU following reports of serious inflammatory...

Read Summary

SPS comment

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 22 June 2018

A pooled analysis has shown an increased rate of new primary malignancies in patients given Xgeva (1-year cumulative incidence 1.1%) compared with those given zoledronic acid (0.6%), when used in the...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 22 June 2018

New safety recommendations have been issued while an EU review evaluates cases of neural tube defects in babies born to mothers who became pregnant while taking the HIV medicine dolutegravir.

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 24 May 2018

Train patients to place the Braltus capsule in the correct chamber of the Zonda inhaler. We have received reports of patients who have inhaled a Braltus capsule from the mouthpiece into the back of...

Read Summary

Type:

Safety Alerts (Add filter)

Source:

GOV UK (Add filter)

Source:

Medicines and Healthcare products Regulatory Agency - MHRA (Remove filter)

Published by Medicines and Healthcare products Regulatory Agency, 24 May 2018

Use materials online now and hardcopies arriving over the coming weeks by post to ensure women and girls of childbearing potential on valproate medicines meet the requirements of the Pregnancy...

Read Summary

Type:

Safety Alerts (Add filter)